Leproust Emily M. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Leproust Emily M. has filed 9 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $11.86M.

Profile

Emily M. Leproust is the Chief Executive Officer of Twist Bioscience Corp, a company specializing in synthetic biology and DNA synthesis. Under her leadership, the company has developed innovative technologies that enhance the efficiency and affordability of DNA production.

Board memberships

• Twist Bioscience Corp

Awards & honors

• CEO of Twist Bioscience Corp
• Pioneered a semiconductor-based DNA synthesis platform
• Led the company to significant growth in the synthetic biology sector

Recent Transactions

Companies — Last 90 Days

• Twist Bioscience Corp (TWST) — 8 filings, last 2026-06-26
• GeneDx Holdings Corp. (WGS) — 1 filings, last 2026-06-23

Frequently Asked Questions

Who is Leproust Emily M.?

Emily M. Leproust is the Chief Executive Officer of Twist Bioscience Corp, a company specializing in synthetic biology and DNA synthesis. Under her leadership, the company has developed innovative technologies that enhance the efficiency and affordability of DNA production.…

How many SEC Form 4 filings has Leproust Emily M. submitted recently?

9 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Leproust Emily M. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 32 open-market sales ($11.86M) across all tracked filings.

Where can I see all of Leproust Emily M.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week